Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 65

1.

Standardisation framework for the Maudsley staging method for treatment resistance in depression.

Fekadu A, Donocik JG, Cleare AJ.

BMC Psychiatry. 2018 Apr 11;18(1):100. doi: 10.1186/s12888-018-1679-x.

2.

Treatment Changes in General Practice Patients With Chronic Mental Disorders Following a Psychiatric-Psychosomatic Consultation.

Linden M, Muschalla B, Noack N, Heintze C, Doepfmer S.

Health Serv Res Manag Epidemiol. 2018 Mar 15;5:2333392818758523. doi: 10.1177/2333392818758523. eCollection 2018 Jan-Dec.

3.
4.

Cognitive and Behavioral Skills Exercises Completed by Patients with Major Depression During Smartphone Cognitive Behavioral Therapy: Secondary Analysis of a Randomized Controlled Trial.

Furukawa TA, Horikoshi M, Fujita H, Tsujino N, Jinnin R, Kako Y, Ogawa S, Sato H, Kitagawa N, Shinagawa Y, Ikeda Y, Imai H, Tajika A, Ogawa Y, Akechi T, Yamada M, Shimodera S, Watanabe N, Inagaki M, Hasegawa A.

JMIR Ment Health. 2018 Jan 11;5(1):e4. doi: 10.2196/mental.9092.

5.

Significant Need for a French Network of Expert Centers Enabling a Better Characterization and Management of Treatment-Resistant Depression (Fondation FondaMental).

Yrondi A, Bennabi D, Haffen E, Garnier M, Bellivier F, Bourgerol T, Camus V, D'Amato T, Doumy O, Haesebaert F, Holtzmann J, Lançon C, Vignaud P, Moliere F, Nieto I, Richieri RM, Domenech P, Rabu C, Mallet L, Yon L, Schmitt L, Stephan F, Vaiva G, Walter M, Llorca PM, Courtet P, Leboyer M, El-Hage W, Aouizerate B.

Front Psychiatry. 2017 Nov 24;8:244. doi: 10.3389/fpsyt.2017.00244. eCollection 2017.

6.

Smartphone Cognitive Behavioral Therapy as an Adjunct to Pharmacotherapy for Refractory Depression: Randomized Controlled Trial.

Mantani A, Kato T, Furukawa TA, Horikoshi M, Imai H, Hiroe T, Chino B, Funayama T, Yonemoto N, Zhou Q, Kawanishi N.

J Med Internet Res. 2017 Nov 3;19(11):e373. doi: 10.2196/jmir.8602.

7.

A Review of the Conceptualisation and Risk Factors Associated with Treatment-Resistant Depression.

Murphy JA, Sarris J, Byrne GJ.

Depress Res Treat. 2017;2017:4176825. doi: 10.1155/2017/4176825. Epub 2017 Aug 3. Review.

8.

Investigational drugs in recent clinical trials for treatment-resistant depression.

Garay RP, Zarate CA Jr, Charpeaud T, Citrome L, Correll CU, Hameg A, Llorca PM.

Expert Rev Neurother. 2017 Jun;17(6):593-609. doi: 10.1080/14737175.2017.1283217. Epub 2017 Jan 29. Review.

PMID:
28092469
9.

Accelerated Intermittent Theta Burst Stimulation for Suicide Risk in Therapy-Resistant Depressed Patients: A Randomized, Sham-Controlled Trial.

Desmyter S, Duprat R, Baeken C, Van Autreve S, Audenaert K, van Heeringen K.

Front Hum Neurosci. 2016 Sep 27;10:480. eCollection 2016.

10.

Dextroamphetamine and Pramipexole Combination for Treatment-Resistant Unipolar Depression.

Koola MM, Fawcett J.

Psychiatr Ann. 2016 Aug;46(8):429-431. Epub 2016 Aug 12. No abstract available.

11.

The influence of prescription opioid use duration and dose on development of treatment resistant depression.

Scherrer JF, Salas J, Sullivan MD, Schneider FD, Bucholz KK, Burroughs T, Copeland L, Ahmedani B, Lustman PJ.

Prev Med. 2016 Oct;91:110-116. doi: 10.1016/j.ypmed.2016.08.003. Epub 2016 Aug 3.

12.

Cushing's Syndrome Masquerading as Treatment Resistant Depression.

Anil Kumar BN, Grover S.

Indian J Psychol Med. 2016 May-Jun;38(3):246-8. doi: 10.4103/0253-7176.183095.

13.

A retrospective study of predictive factors for effective aripiprazole augmentation of antidepressant therapy in treatment-resistant depression.

Sugawara H, Sakamoto K, Harada T, Shimizu S, Ishigooka J.

Neuropsychiatr Dis Treat. 2016 May 10;12:1151-6. doi: 10.2147/NDT.S104115. eCollection 2016.

14.

Processing of emotional stimuli is reflected by modulations of beta band activity in the subgenual anterior cingulate cortex in patients with treatment resistant depression.

Huebl J, Brücke C, Merkl A, Bajbouj M, Schneider GH, Kühn AA.

Soc Cogn Affect Neurosci. 2016 Aug;11(8):1290-8. doi: 10.1093/scan/nsw038. Epub 2016 Mar 24.

15.

Perils of Pragmatic Psychiatry: How We Can Do Better.

Koola MM, Sebastian J.

HSOA J Psychiatry Depress Anxiety. 2016;2(1). pii: 002. Epub 2016 Feb 23.

16.

Association of thalamic hyperactivity with treatment-resistant depression and poor response in early treatment for major depression: a resting-state fMRI study using fractional amplitude of low-frequency fluctuations.

Yamamura T, Okamoto Y, Okada G, Takaishi Y, Takamura M, Mantani A, Kurata A, Otagaki Y, Yamashita H, Yamawaki S.

Transl Psychiatry. 2016 Mar 8;6:e754. doi: 10.1038/tp.2016.18.

17.

Update on Neuromodulation for Treatment-Resistant Depression.

Bewernick B, Schlaepfer TE.

F1000Res. 2015 Dec 2;4. pii: F1000 Faculty Rev-1389. doi: 10.12688/f1000research.6633.1. eCollection 2015. Review.

18.

Treatment-Resistant Major Depression: Rationale for NMDA Receptors as Targets and Nitrous Oxide as Therapy.

Zorumski CF, Nagele P, Mennerick S, Conway CR.

Front Psychiatry. 2015 Dec 9;6:172. doi: 10.3389/fpsyt.2015.00172. eCollection 2015. Review.

19.

Proteasome system dysregulation and treatment resistance mechanisms in major depressive disorder.

Minelli A, Magri C, Barbon A, Bonvicini C, Segala M, Congiu C, Bignotti S, Milanesi E, Trabucchi L, Cattane N, Bortolomasi M, Gennarelli M.

Transl Psychiatry. 2015 Dec 1;5:e687. doi: 10.1038/tp.2015.180.

20.

A Case of Electroconvulsive Therapy-Resistant Depression Responding to Multiple Dopaminergic Medications.

Koola MM, Fawcett JA.

Prim Care Companion CNS Disord. 2015 Apr 30;17(2). doi: 10.4088/PCC.14l01745. eCollection 2015. No abstract available.

Supplemental Content

Support Center